SEC Tracker
Get the app

Intellia Therapeutics NTLA

Jing L. Marantz (Officer) was awarded 199,822 NTLA

Form
4
Filed
Importance
Routine
  1. Marantz Jing L. acquired 199,822 shares of common stock.
  2. Marantz Jing L. received 275,061 stock options.
  3. The stock options expire on Oct 25, 2036.
  4. Marantz Jing L. is the EVP, Chief Medical Officer.

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Intellia Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2835 and related industry codes: the same peer list as the financial tables.

  1. Geron GERN public float $861M, Jun 30, 2025
  2. Wave Life Sciences WVE public float $851M, Jun 30, 2025
  3. Cyanotech CYAN
  4. CorMedix CRMD public float $910M, Jun 30, 2025
  5. Ardelyx ARDX public float $924M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.